BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

539 related articles for article (PubMed ID: 17699324)

  • 21. Renal cysts and hypokalemia in primary aldosteronism: results of long-term follow-up after treatment.
    Novello M; Catena C; Nadalini E; Colussi GL; Baroselli S; Chiuch A; Lapenna R; Bazzocchi M; Sechi LA
    J Hypertens; 2007 Jul; 25(7):1443-50. PubMed ID: 17563567
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Screening for primary aldosteronism in a primary care unit.
    Volpe C; Wahrenberg H; Hamberger B; Thorén M
    J Renin Angiotensin Aldosterone Syst; 2013 Sep; 14(3):212-9. PubMed ID: 23118039
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Primary aldosteronism: renaissance of a syndrome.
    Young WF
    Clin Endocrinol (Oxf); 2007 May; 66(5):607-18. PubMed ID: 17492946
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Hypertension secondary to primary aldosteronism].
    Omura M; Saito T; Saito J; Soyama A; Nishikawa T
    Nihon Rinsho; 2004 Mar; 62 Suppl 3():521-5. PubMed ID: 15171428
    [No Abstract]   [Full Text] [Related]  

  • 25. Influence of antihypertensive medication on aldosterone and renin concentration in the differential diagnosis of essential hypertension and primary aldosteronism.
    Seifarth C; Trenkel S; Schobel H; Hahn EG; Hensen J
    Clin Endocrinol (Oxf); 2002 Oct; 57(4):457-65. PubMed ID: 12354127
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Current diagnosis and treatment of primary aldosteronism.
    Kaplan NM
    Expert Rev Cardiovasc Ther; 2010 Nov; 8(11):1527-30. PubMed ID: 21090927
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Acute response to calcium inhibitors in secondary arterial hypertension: does renin play a role?].
    Jeunemaitre X; Valenta de Almeida L; Sassano P; Farge D; Guyene TT; Julien J; Plouin PF; Corvol P
    Arch Mal Coeur Vaiss; 1988 Jun; 81 Spec No():141-4. PubMed ID: 3142397
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [What tests should be conducted for secondary arterial hypertension in hypertensive patients resistant to treatment?].
    Denolle T; Hanon O; Mounier-Vehier C; Marquand A; Fauvel JP; Laurent P; Tison E; Equine O; Ducloux D; Girerd X
    Arch Mal Coeur Vaiss; 2000 Aug; 93(8):1037-9. PubMed ID: 10989753
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Primary aldosteronism, diagnosed by the aldosterone to renin ratio, is a common cause of hypertension.
    Lim PO; MacDonald TM
    Clin Endocrinol (Oxf); 2003 Oct; 59(4):427-30. PubMed ID: 14510903
    [No Abstract]   [Full Text] [Related]  

  • 30. Blood pressure and medication changes following adrenalectomy for unilateral primary aldosteronism: a follow-up study.
    van der Linden P; Steichen O; Zinzindohoué F; Plouin PF
    J Hypertens; 2012 Apr; 30(4):761-9. PubMed ID: 22252482
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Endocrine arterial hypertension: therapeutic approach in clinical practice.
    Mazza A; Armigliato M; Zamboni S; Rempelou P; Rubello D; Pessina AC; Casiglia E
    Minerva Endocrinol; 2008 Dec; 33(4):297-312. PubMed ID: 18923367
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Normokalemic primary hyperaldosteronism].
    Vonend O; Rump LC
    Dtsch Med Wochenschr; 2006 Nov; 131(46 Spec No):H24-7. PubMed ID: 17109245
    [No Abstract]   [Full Text] [Related]  

  • 33. Cardiovascular outcomes in patients with primary aldosteronism after treatment.
    Catena C; Colussi G; Nadalini E; Chiuch A; Baroselli S; Lapenna R; Sechi LA
    Arch Intern Med; 2008 Jan; 168(1):80-5. PubMed ID: 18195199
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence of hyperaldosteronism in primary care patients with resistant hypertension.
    Schmiemann G; Gebhardt K; Hummers-Pradier E; Egidi G
    J Am Board Fam Med; 2012; 25(1):98-103. PubMed ID: 22218630
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Resistant hypertension - progress in diagnosis and treatment].
    Szwench E; Florczak E; Prejbisz A; Kądziela J; Witkowski A; Januszewicz A
    Kardiol Pol; 2012; 70(1):66-74. PubMed ID: 22267432
    [No Abstract]   [Full Text] [Related]  

  • 36. Screening Rates for Primary Aldosteronism in Resistant Hypertension: A Cohort Study.
    Jaffe G; Gray Z; Krishnan G; Stedman M; Zheng Y; Han J; Chertow GM; Leppert JT; Bhalla V
    Hypertension; 2020 Mar; 75(3):650-659. PubMed ID: 32008436
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antihypertensives.
    Cranwell-Bruce LA
    Medsurg Nurs; 2008 Oct; 17(5):337-41; quiz 342. PubMed ID: 19051983
    [No Abstract]   [Full Text] [Related]  

  • 38. [Primary hyperaldosteronism in hypertension].
    Girerd X
    Rev Med Suisse; 2008 Sep; 4(170):1924-6. PubMed ID: 18847121
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Primary aldosteronism: considerations about the evaluation of the aldosterone to renin ratio during canrenone treatment.
    Armanini D; Sabbadin C; Boscaro M
    J Endocrinol Invest; 2021 Sep; 44(9):2009-2010. PubMed ID: 33454931
    [No Abstract]   [Full Text] [Related]  

  • 40. Aldosterone-to-renin ratio as a screening test for primary aldosteronism--the Dutch ARRAT Study.
    Jansen PM; Boomsma F; van den Meiracker AH;
    Neth J Med; 2008 May; 66(5):220-8. PubMed ID: 18490805
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.